NICHOLE VANELLS: Open Payments
NPI 1952659377 · EAST LANSING, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,091 in 41 payments from 17 companies in 2025. Trend: 2023 $2,143 · 2024 $3,960 · 2025 $1,091
Food & beverage: $1,091
| Company | Payments | Amount |
|---|---|---|
| Biogen, Inc. | 7 | $172 |
| ARGENX US, INC. | 3 | $162 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $126 |
| Vanda Pharmaceuticals Inc. | 4 | $104 |
| Genentech USA, Inc. | 3 | $86 |
| UCB, Inc. | 5 | $82 |
| Alnylam Pharmaceuticals Inc. | 2 | $64 |
| Alexion Pharmaceuticals, Inc. | 2 | $51 |
| PFIZER INC. | 2 | $39 |
| JAZZ PHARMACEUTICALS INC. | 2 | $39 |
Products named: TYSABRI, HYQVIA, VYVGART, PONVORY, ONPATTRO, VYVGART HYTRULO, ULTOMIRIS, Ocrevus Zunovo.
Industry payments across MI — which companies pay providers there.
